Page last updated: 2024-12-07
pimprinine
Description
Pimprinine is a natural product isolated from the medicinal plant *Piper longum* (long pepper). It exhibits a range of biological activities, including anti-inflammatory, analgesic, and antioxidant properties. Research on pimprinine is motivated by its potential therapeutic applications in treating inflammatory conditions and pain. Studies have shown that pimprinine can inhibit the production of pro-inflammatory cytokines and mediators, suggesting its potential as an anti-inflammatory agent. Its antioxidant properties have also been linked to its ability to scavenge free radicals, which can contribute to oxidative stress and damage. Further research is ongoing to fully understand the mechanism of action of pimprinine and explore its potential as a therapeutic agent.'
pimprinine: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 96578 |
SCHEMBL ID | 12364396 |
MeSH ID | M0053175 |
Synonyms (27)
Synonym |
nsc-80793 |
nsc80793 |
pimprinine |
pimprinine (hindustan antibiotic) |
13640-26-1 |
5-(1h-indol-3-yl)-2-methyl-1,3-oxazole |
1h-indole, 3-(2-methyl-5-oxazolyl)- |
AKOS006287160 |
crw4nit4w1 , |
nsc 80793 |
5,3'-indolyl-2-methyloxazole |
unii-crw4nit4w1 |
CCG-40387 |
5-(1h-indol-3-yl)-2-methyl-oxazole |
SCHEMBL12364396 |
HB4028 |
DTXSID80159782 |
J-006842 |
3-(2-methyl-5-oxazolyl)-1h-indole |
3-(2-methyl-1,3-oxazol-5-yl)-1h-indole |
NCGC00507755-01 |
antibiotic ws 30581c |
5-(3-indolyl)-2-methyloxazole |
5-(1h-indol-3-yl)-2-methyloxazole |
Z1198175856 |
HY-120769 |
CS-0079119 |
Research
Studies (11)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 4 (36.36) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 21.82
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 21.82 (24.57) | Research Supply Index | 2.48 (2.92) | Research Growth Index | 5.01 (4.65) | Search Engine Demand Index | 18.60 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |